retatrutide ly3437943 triple agonist glp-1 gip glucagon LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof of concept Retatrutide Research: Triple Agonist Mechanism
Description
GLP-1 nausea vs DPP4 neutral GI
oral regimens), and trial endpoints better tuned to metabolic mechanisms
This is a huge market
Fayetteville NC Ozempic Weight Loss Injections at Cape Fear Physical Medicine & Rehab
